NG Solution Team
Technology

How can you invest in China’s ChatGPT competitors through a new ETF?

American investors now have a fresh opportunity to tap into China’s burgeoning artificial intelligence sector without the need for a VPN or language lessons. The Themes China Generative AI ETF, trading under the ticker DRGN, has been introduced as the first U.S.-listed fund dedicated solely to Chinese companies that are at the forefront of the generative AI movement. Launched on July 15, this ETF boasts a competitive expense ratio of 0.39%, making it one of the most cost-effective options in the AI-focused ETF space.

Moving beyond the usual focus on U.S. tech giants like Nvidia and Microsoft, DRGN offers exposure to a dynamic and often overlooked segment of the AI industry: China’s innovative talent pool. According to Paul Marino, Themes ETFs’ chief revenue officer, Chinese expertise in AI surpasses many expectations, with some of the world’s leading AI specialists emerging from the region. This ETF allows American investors to participate in this growth without leaving U.S. markets.

DRGN follows the BITA China Generative AI Select Index, which includes publicly traded Chinese companies in the U.S., Hong Kong, or those accessible via Stock Connect. These companies significantly engage in generative AI activities such as model training, application software development, and AI infrastructure.

This marks the 19th fund launched by Themes ETFs since its inception in December 2023. Known for its focus on niche technology and thematic investments, the firm also offers funds in areas like cybersecurity, defense, cloud computing, as well as sectors like gold mining, banking, and U.S. infrastructure.

Related posts

Is AI enhancing workflows rather than replacing them in cinema?

Emily Brown

كيف يتفاعل الجذر التربيعي مع عدم توازن الطلب والتقلب؟

Is China Leading the AI World Amid Geopolitical Strains?

Michael Johnson

Leave a Comment

This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info

Privacy & Cookies Policy